A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2011
12/29/2011	WO2011162343A1 Antitumor agent using compounds having kinase inhibitory effect in combination
12/29/2011	WO2011162320A1 Combination of egcg or methylated egcg and a pde inhibitor
12/29/2011	WO2011162300A1 Crystal of fused pyridine compound salt
12/29/2011	WO2011161970A1 Anti-pdgf receptor antibody
12/29/2011	WO2011161631A2 Compounds for treatment of tumors bearing deregulated myc oncoproteins
12/29/2011	WO2011161256A1 Beta carboline derivatives useful in the treatment of proliferative disorders
12/29/2011	WO2011161244A1 Homodimeric protein constructs
12/29/2011	WO2011161220A1 Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
12/29/2011	WO2011161216A1 Heteroaryl compounds and compositions as protein kinase inhibitors
12/29/2011	WO2011161201A1 Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer
12/29/2011	WO2011161151A1 Use of dibenzofuranone derivatives to inhibit kinases
12/29/2011	WO2011161065A1 Macrocyclic tetrapyrrolic compound of the family of porphyrins, chlorins and bacteriochlorins as photosensitizers for photodynamic therapy
12/29/2011	WO2011161031A1 Benzotriazolodiazepine compounds inhibitors of bromodomains
12/29/2011	WO2011160632A1 Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors
12/29/2011	WO2011160429A1 Anti-p185（her2/erbb2）humanized antibodies
12/29/2011	WO2011160425A1 Preparing method of allicin injection and low temperature continuous stirring ultrafiltration device thereof
12/29/2011	WO2011160189A1 METHOD OF SCREENING FOR INHIBITORS OF sPLA2-IIA
12/29/2011	WO2011160174A1 Treatment of proliferative diseases
12/29/2011	WO2011160170A1 Stimulating immune response
12/29/2011	WO2011128701A3 Cancer methods
12/29/2011	WO2011114071A3 Synthetic cyclopeptide, preparation process and uses
12/29/2011	WO2011113041A3 Neutralization of flt3 ligand as a leukemia therapy
12/29/2011	WO2011109767A3 Gelatinase inhibitors and prodrugs
12/29/2011	WO2011109422A3 Compositions and methods for the treatment of cancer
12/29/2011	WO2011109237A9 Uses of noscapine and derivatives in subjects diagnosed with fap
12/29/2011	WO2011103586A3 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine
12/29/2011	WO2011100468A3 Methods and materials for treating cancer
12/29/2011	WO2011097573A3 Methods and compositions for cancer immunotherapy using flagellin-tumor associated antigen fusion protein expressing tumor cells
12/29/2011	WO2011097500A3 The tweak/fn14 system regulates skeletal muscle atrophy and regeneration
12/29/2011	WO2011090349A3 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties
12/29/2011	WO2011090297A3 Human adult stem cell for expressing anti-mdm2, and use thereof
12/29/2011	WO2011089602A3 Aloe-emodin derivatives and use thereof for the treatment of cancer
12/29/2011	WO2010132882A8 Sublingual dexmedetomidine compositions and methods of use thereof
12/29/2011	WO2010084157A8 Multifunctional stealth nanoparticles for biomedical use
12/29/2011	WO2009153319A8 Anti-tumour compositions and methods
12/29/2011	US20110319869 Human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
12/29/2011	US20110319599 MN Gene and Protein
12/29/2011	US20110319494 Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents
12/29/2011	US20110319493 Histone deacetylases, and uses related thereto
12/29/2011	US20110319486 Stabilized ascorbic acid solutions; method of use thereof; process for their obtention; and compositions comprising the same
12/29/2011	US20110319483 1-adamantyl chalcones for the treatment of proliferative disorders
12/29/2011	US20110319482 Novel treatments
12/29/2011	US20110319481 Schweinfurthin analogues
12/29/2011	US20110319480 Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens
12/29/2011	US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
12/29/2011	US20110319475 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
12/29/2011	US20110319472 Methods of prognosticating and treating ewing sarcoma/pnet and other neoplasms
12/29/2011	US20110319471 Lna antagonists targeting the androgen receptor
12/29/2011	US20110319470 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
12/29/2011	US20110319468 Cyclic amine compounds
12/29/2011	US20110319465 Estrogen receptor modulators and uses thereof
12/29/2011	US20110319460 Kinase inhibitors
12/29/2011	US20110319458 Compound with agitation effect on peroxisome proliferator-activated receptor. process for its preparation and use thereof
12/29/2011	US20110319447 Triazole compounds that modulate hsp90 activity
12/29/2011	US20110319445 Heteroaryl antagonists of prostaglandin d2 receptors
12/29/2011	US20110319443 Inhibitors of akt activity
12/29/2011	US20110319442 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
12/29/2011	US20110319436 Methods and Compositions for Modulating IRE1, SRC, and ABL Activity
12/29/2011	US20110319429 Substituted 1,1,3,1-tetraoxidobenzo[d][1,3,2]dithiazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
12/29/2011	US20110319427 Use of 5ahq and bortezomib for the treatment of hematological diseases
12/29/2011	US20110319420 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor
12/29/2011	US20110319419 Methotrexate Adjuvants to Reduce Toxicity and Methods for Using the Same
12/29/2011	US20110319415 Susceptibility to HSP90-Inhibitors
12/29/2011	US20110319411 Isoindolinone and related analogs as sirtuin modulators
12/29/2011	US20110319410 Pyrazine derivatives and use as pi3k inhibitors
12/29/2011	US20110319408 Methods of Treating Fibrosis, Cancer and Vascular Injuries
12/29/2011	US20110319406 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors
12/29/2011	US20110319404 Method for treating non-hodkin's lymphoma
12/29/2011	US20110319401 Five crystal forms, methods of preparation, pharmaceutical compositions and applications of xlf-iii-43
12/29/2011	US20110319392 Thiazole Sulfonamide And Oxazole Sulfonamide Kinase Inhibitors
12/29/2011	US20110319390 6-Aminoisoquinoline Compounds
12/29/2011	US20110319381 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
12/29/2011	US20110319378 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
12/29/2011	US20110319369 Combination of a 17 alpha-hydroxylase/c17, 20-lyase inhibitor with an additional therapeutic agent
12/29/2011	US20110319365 Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
12/29/2011	US20110319362 Stat3 ligands and therapeutic uses thereof
12/29/2011	US20110319360 Method of including apoptosis/Cell death in leukemia cell using a purine nucleoside analogue
12/29/2011	US20110319359 Indanyl compounds
12/29/2011	US20110319355 Methods for treating non-small cell lung cancer using 5-azacytidine
12/29/2011	US20110319354 Combination Cancer Therapy with an AKT Inhibitor and Other Anticancer Agents
12/29/2011	US20110319352 Compounds That Bind Oxysterol Binding Proteins, and Methods of Use Thereof
12/29/2011	US20110319351 Treating cancer with cardiac glycosides
12/29/2011	US20110319350 Glycoside compounds and pharmaceutical compositions thereof
12/29/2011	US20110319345 Combination Therapy for Treatment of Cancer
12/29/2011	US20110319343 Agonists Of Guanylate Cyclase Useful For The Treatment Of Gastrointestinal Disorders, Inflammation, Cancer And Other Disorders
12/29/2011	US20110319340 Methods for treating cancer
12/29/2011	US20110319339 Neurotensin-derived branched peptides and uses thereof
12/29/2011	US20110319338 Peptides that bind eukaryotic translation initiation factor 4e
12/29/2011	US20110319337 Dominant Negative WNT2 Compositions and Methods of Use
12/29/2011	US20110319336 Selective anticancer chimeric peptide
12/29/2011	US20110319335 Combined administration of integrin receptor antagonists for anti-angiogenic therapy
12/29/2011	US20110319332 Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
12/29/2011	US20110319326 Derivatives of benzothiazines, preparation thereof and application thereof as drugs
12/29/2011	US20110319323 Pharmaceutical composition and method of use to improve organ function
12/29/2011	US20110319321 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
12/29/2011	US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
12/29/2011	US20110319267 Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
12/29/2011	US20110318834 Multiple-tumor aberrant growth genes
12/29/2011	US20110318832 Human Telomerase Catalytic Subunit
12/29/2011	US20110318439 Plant extracts from acronychia species and their use

1 ... 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 ... 2211